Analyst EPS Change
Set Up E-mail Alerts For Analyst EPS Change » RSS Feed For Analyst EPS Change »
This category tracks notable EPS changes from analysts on Wall Street. For a summary of today's earnings movers and an earnings calendar please visit EPS Insider.
More Analyst EPS Change
View Older Stories View More Recent Stories-
Goldman Sachs Starts Safeway (SWY) at Sell, Sees 17% Downside
-
UBS Adjusts Numbers on Dean Foods (DF) Ahead of Partial Spin Off
-
JPMorgan (JPM) Trading Off to a Strong Start in Q2; Estimates Raised at Evercore
-
Canaccord Genuity Lifts PT on Stratasys (SSYS) to $95
-
Needham & Company Remains on Sidelines with SolarCity (SCTY)
-
UPDATE: UBS Upgrades Fusion-io (FIO) to Buy
-
Needham & Company Lifts Price Target on Stratasy (SSYS); Sees 10% Upside
-
Jefferies Sees Light Q1 SSS for Kohl's (KSS) But Likes the Stock
-
TD Securities Downgrades Lone Pine Resources (LPR) to Hold
-
Jefferies Cuts Numbers on Endo Pharmaceuticals (ENDP) After 'Irrational' FDA Decision
-
Jefferies Upgrades Express Scripts (ESRX) to Buy; Uncertainties Gone & Repurchases Back
-
Jefferies Upgrades DuPont Fabros Technology (DFT) to Buy, Sees 22% Upside
-
Deutsche Bank Sees Improvement at MEMC Electronic (WFR)
-
Jefferies Lifts PT on Vanda Pharmaceuticals (VNDA) to $7
-
Anadarko (APC) Stock Cheap with Major Upcoming Catalysts - Jefferies
-
A Big Deal May Be in the Works for TreeHouse Foods (THS)
-
MKM Partners Slighly Increases Amarin (AMRN) Vascepa Estimates Post Q1
-
Jefferies Boosts PT on MEMC Electronic Materials (WFR) to $5
-
Maxim Group Downgrades Starz (STRZA) to Hold
-
Jefferies Cuts Numbers on Edgen Groug (EDG) Aheead of Q1 Print
-
Jefferies More Bullish on Aegerion Pharmaceuticals (AEGR) Following Lipidologists Survey
-
WageWorks (WAGE) Post Solid Q1; Numbers Raised at Needham & Company
-
Needham & Company Boosts PT on NeoPhotonics (NPTN) Post Q1
-
Needham & Company Upgrades Park Electrochemical (PKE) to Buy
-
Wells Fargo Upgrades Boston Scientific (BSX) to Outperform
-
Goldman Sachs Upgrades Granite Construction (GVA) to Neutral
-
UBS Maintains Buy on Monster Beverage (MNST)
-
Goldman Adjusts Numbers on Tumi (TUMI)
-
Risk/Reward Still Favors Owning Groupon (GRPN) - Goldman
-
Jefferies Lifts Numbers on EOG Resources (EOG) on Eagle Ford Acceleration
-
Jefferies Lifts Numbers on Oasis Petroleum (OAS)
-
Brean Capital Upgrades Maidenform Brands (MFB) to Buy
-
Goldman Sachs Downgrades Tesla Motors (TSLA) to Neutral
-
Needham & Company Lifts Numbers on Financial Engines (FNGN) on Strong Q1
-
Needham & Company Cuts Numbers on ESCO Technologies (ESE) on Weak Q1
-
Walt Disney (DIS) PT Raised at Nomura Following Strong Q2
-
Aruba Networks (ARUN) Blasted on Q3 Warnings, But Deals Still There Says Analyst
-
Jefferies Cuts Numbers on Frontier Comm (FTR), Still Sees 22% Upside
-
Jefferies Boosts PT on RigNet (RNET) to $27
-
Sagent Pharmaceuticals (SGNT) Guidance Conservative - Jefferies
-
Insulet (PODD) OmniPod Adoption to Fuel Strong Growth - Jefferies
-
Jefferies Lifts PT on Laboratory Corp (LH) to $100
-
Needham & Company Staying on the Sidelines with First Solar (FSLR) Post Q1
-
Short Covering to Drive Tesla (TSLA) Higher - Jefferies
-
Jefferies Cuts PT on Swift Energy (SFY) 32%, Keeps Buy Rating
-
Hain Celestial (HAIN) PT Trimmed at Jefferies, Still Sees 17% Upside
-
Blackstone Group (BX) Price Target Raised at Jefferies, Sees 15% Upside
-
BlackBerry (BBRY) BB10 Sellin Estimates Cut at Canaccord Genuity; Weak Z10 Offset by Solid Q10
-
Maxim Group Raises PT on Madison Square (MSG), Sees 24% Upside
-
Needham & Company Lifts Numbers on Cubic (CUB) on 'Strong' Q2
